Hansen Pharmaceuticals: Net profit in 2024 was 220 million yuan, a year-on-year increase of 7.43%.

Hansen Pharmaceutical announced that its operating income in 2024 was 1.004 billion yuan, an increase of 5.12% year-on-year. The net profit attributable to shareholders of the listed company was 220 million yuan, an increase of 7.43% year-on-year. The basic earnings per share were 0.4377 yuan per share, an increase of 7.44% year-on-year. The company plans not to distribute cash dividends, bonus shares, or increase capital from surplus reserves.